| Name | Title | Contact Details |
|---|
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
BirdDog Solutions is the leading provider of Parcel Shipping and Logistics Optimization services. We are the first in the industry to integrate carrier contract optimization with comprehensive invoice auditing, payment processing, and information
Carter, Milchman & Frank is a Long Island City, NY-based company in the Business Services sector.
Pep is a Cincinnati, OH-based company in the Business Services sector.
BTB Solution is a Seoul, IL-based company in the Business Services sector.